Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in Association with Vedolizumab Drug Levels.

Autor: Hüttemann, Eva1,2 (AUTHOR) eva.huettemann@kssg.ch, Muzalyova, Anna1 (AUTHOR) katharina.groehl@uk-augsburg.de, Gröhl, Katharina1 (AUTHOR) sandra.nagl@uk-augsburg.de, Nagl, Sandra1 (AUTHOR) carola.fleischmann@klinikum-nuernberg.de, Fleischmann, Carola1,3 (AUTHOR) alanna.ebigbo@uk-augsburg.de, Ebigbo, Alanna1 (AUTHOR) johanna-maria.classen@uk-augsburg.de, Classen, Johanna1 (AUTHOR) julia.wanzl@uk-augsburg.de, Wanzl, Julia1 (AUTHOR) rik.pri@gmx.de, Prinz, Friederike1 (AUTHOR), Mayr, Patrick4,5 (AUTHOR) patrick.mayr@kssg.ch, Schnoy, Elisabeth1 (AUTHOR) eva.huettemann@kssg.ch
Zdroj: Journal of Clinical Medicine. Jan2024, Vol. 13 Issue 1, p140. 17p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje